Asclera Injection, Solution
Product Images NDC 67850-141

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Asclera (NDC 67850-141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Methapharm, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Asclera 01)

Chemical structure diagram of polidocanol, the active ingredient in Asclera injection solution. The image shows the molecular arrangement including hydrocarbon chains and polyoxyethylene groups, indicating the polymeric nature of polidocanol.*

FDA Label Image

Principal Display Panel (10 mg Ampule Carton)

Packaging label for Asclera (polidocanol) Injection 0.5%, 10 mg per 2 mL (5 mg per mL) solution for intravenous use. Includes drug concentration, dosage form, and usage instructions. Distributed by Methapharm, Inc and licensed from Kreussler Pharma, Germany. Contains five 2 mL ampules per package.*

FDA Label Image

Principal Display Panel (20 mg Ampule Carton)

Packaging label for Asclera (polidocanol) Injection 1% solution, 20 mg per 2 mL (10 mg per mL) intravenous use. The label is primarily purple with white and yellow text, showing the product name, strength, and usage instructions. The labeler is Methapharm, Inc, and the package contains 5 ampules each with 20 mg per 2 mL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.